Antidepressants and Metaphysics: A Philosophical Lens on Emotional Blunting

By: Archana Murugan, PharmD Candidate c/o 2029

Introduction

Antidepressants are a class of medications commonly prescribed to help with an individual’s mood or behavior, specifically targeting the serotonin levels in the body. Existentialism, transcendentalism, and deconstruction represent prominent movements in metaphysics and can be used to explain the effects of antidepressants on an individual’s perception. Plato’s Allegory of the Cave further illustrates these three philosophical movements, which can also be connected back to the effects of antidepressants. This raises an important question: how do antidepressants alter our perception of self and identity?

Scientific Insight: Emotional Blunting and Serotonin

Scientists from the University of Cambridge in collaboration with the University of Copenhagen, sought to understand why half of common antidepressant users experience emotional “blunting.” They conducted a study with 66 volunteers – 32 took escitalopram (a selective serotonin reuptake inhibitor, or SSRI) while 34 received a placebo.1 After analyzing the data, researchers “found that participants taking escitalopram were less likely to use the positive and negative feedback to guide their learning of the task compared with participants on placebo.”1 This suggests that escitalopram affects individuals’ sensitivity to rewards and their ability to respond adaptively, thereby impairing reinforcement learning, a key process for environmental adaptation. Emotional blunting and serotonin-related effects among antidepressant users can therefore be directly linked with the metaphysical studies of existentialism, transcendentalism, and deconstruction.

Existentialism and the Search for Meaning

Existentialism is a philosophical framework that prioritizes the significance of individual existence and the quest for meaning. Referring to Allegory of the Cave, individuals are described as confined captives where their perception is restricted to just shadows, representing a constrained comprehension of reality. Escaping the cave signifies the profound existential quest for knowledge and authentic existence. When serotonin levels fluctuate, patients may experience side effects ranging from mild to severe. In some cases, patients experience “serotonin syndrome”- characterized by “altered mental status, autonomic dysfunction, and neuromuscular excitation” – which can significantly affect daily life.2 Patients experiencing the psychological and physical side effects of antidepressants may experience internal and social conflicts, thus, it is crucial to navigate these challenges effectively so that individual’s do not continue to “live in the shadows”.

Transcendentalism and the Realm Beyond

Transcendentalism asserts that reality surpasses mere empirical observation, extending into a higher, non-material realm – a concept reflective of Plato’s “Realm of Forms” described in The Republic.3 In the Allegory of the Cave, the freed prisoners encounter the outside world and realize that true reality extends beyond the shadows he once perceived.4 This journey represents the movement toward understanding eternal and unchanging truths.

In the context of antidepressant use, experiences such as emotional blunting, activation anxiety, or serotonin-related alterations may prompt a deeper connection with one’s inner self and surroundings. These experiences can emphasize the importance of self-development and personal insight in overcoming emotional challenges. Through introspection and engagement with their environment, individuals can achieve balance- echoing the transcendentalist belief in the intrinsic goodness of people and nature.

Deconstruction and Neurochemical Understanding  

Deconstruction entails a critical examination of texts to reveal underlying meanings and contradictions. In the cave allegory, while some captives embrace enlightenment and freedom, others remain comfortable in their chains, accepting shadows as their truth. ⁴ The article “Understanding and Managing Antidepressant Side Effects” explores the frequency and consequences of side effects linked to antidepressant use – noting that despite advances in safety and tolerability, such effects remain a significant challenge. Kelly and co-authors reported that among 401 patients with depression, 86% experienced at least one side effect, and 55% experienced one or more bothersome effects. ⁵ Healthcare professionals seem to underestimate the prevalence of these side effects which include sexual dysfunction, gastrointestinal problems, weight gain, insomnia, and fatigue or somnolence.

Much like the prisoners who choose to remain in the cave, some patients persist with treatment despite discomfort, while others discontinue therapy in pursuit of perceived freedom from medication. In general, SSRIs and SNRIs can alter mood and emotional regulation, potentially leading to shifts in how individuals perceive themselves and interact with others. Although an individual doesn’t necessarily choose to withdraw from reality, antidepressants can have the potential to affect one’s personality without warning.

Conclusion

            Pharmacists, as medication experts and accessible healthcare professionals, play a crucial role in guiding patients through antidepressant therapy. Just as Plato’s allegory of the cave encourages individuals to step beyond the shadows in search of light and understanding, pharmacists can help navigate the uncertainties of treatment by providing compassionate care and clear information. Given the diverse mechanisms and effects of antidepressants, collaborative communication between patients and healthcare providers is essential for achieving neurochemical stability and emotional well-being. Supporting patients throughout their journey results not only enhances the individual’s overall well-being but also fosters a renewed sense of purpose and self-awareness.

References

  1. Langley C, Armand S, Luo Q, et al. Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: a double-blind, placebo-controlled semi-randomised study. Neuropsychopharmacology. 2023;48(4):664-670. doi:10.1038/s41386-022-01523-x.
  2. Simon LV, Torrico TJ, Keenaghan M. Serotonin Syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing; March 2, 2024.
  3. Meinwald CC. Plato. Encyclopedia Britannica. Updated August 25, 2025. https://www.britannica.com/biography/Plato/Dialectic#ref281701.
  4. Plato. (1888). The Republic of Plato. (B. Jowett, Trans.). Oxford: Clarendon Press. (c. 375 BC). https://archive.org/details/a604578400platuoft/page/n11/mode/1up.
  5. Kelly K, Posternak M, Alpert JE. Toward achieving optimal response: understanding and managing antidepressant side effects. Dialogues Clin Neurosci. 2008;10(4):409-418. doi:10.31887/DCNS.2008.10.4/kkelly.
eMAR

Recent Posts

Oxidative Stress and Its Impact on Vitiligo

By: Zurriya Faran, PharmD Candidate c/o 2031 The visible loss of skin pigmentation often indicates…

3 months ago

Thiamine Metabolic Dysfunction Syndrome: Overview, importance, MOA, and treatment

By: Archana Murugan, PharmD candidate c/o 2029 Overview             Thiamine metabolic dysfunction syndrome (TMDS) refers…

3 months ago

Updated Guidelines for the Treatment of Multidrug and Rifampin-Resistant TB and Promising New Anti-TB Drugs in Phase 2/3 Trials

By: Kevin Lee, PharmD Candidate c/o 2028, Angela Yin, PharmD Candidate c/o 2028             The…

3 months ago

Sixth Year Perspective: Interview with Ariella Zadrima, PharmD Candidate, c/o 2026

By: Aymon Choudhury, PharmD Candidate c/o 2027 APPE questions: How did your APPE rotations shape…

3 months ago

Foundayo: The New Drug in the GLP-1 market

By: Sariah Grant, PharmD Candidate c/o 2027             The rise of glucagon-like peptide -1 receptor…

3 months ago

Should All Drugs be OTC? Risks and Consequences of the FDA Commissioner Statement

By: Amanda Kastel, PharmD Candidate c/o 2027 In February 2026, FDA Commissioner Marty Makary stated…

3 months ago